Skip to main content
. 2016 Sep 13;2(1):36–43. doi: 10.1016/j.ekir.2016.09.003

Table 1.

Gender, race, and medication in study participants

N Male:
Female		 Race
(AA:C:O)		 Medications
CKD 33 18:15 11:22:0 ACEI/ARB (n = 23)
Control 30 6:24 10:16:4 n/a

AA, African American; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; C, Caucasian; CKD, chronic kidney disease; n/a, not applicable; O, other.